Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

Pending FDA feedback, the Company will also seek FDA orphan drug designation (“ODD”) and NDA marketing approval for the XRx-026 program. Previously, oxypurinol was granted ODD for allopurinol ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA) ...

A-41 does not require an AOM to be from an individual with the same numerous specialties as the defending physician; instead, it requires only the same 'specialty or subspecialty' in the singular," ...

Now, phase 3 results with a new drug from Sobi and Selecta suggests ... current drugs like allopurinol and febuxostat aren’t able to achieve that objective, and there are estimated to be around ...

Current first-line therapies like allopurinol and febuxostat can be very ... Amgen reported sales of $272 million for the drug after it took ownership in 2023 and $235 million in the first quarter ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When ...

They’ll check your uric acid levels to diagnose your condition. Sometimes, they may prescribe a drug such as allopurinol (Zyloprim) or febuxostat (Uloric) to lower your uric acid levels.

taking advantage of the drug interaction) Jantoven (warfarin), a prescription blood thinner Zyloprim (allopurinol), a prescription medication used to prevent gout This is not a full list of drug ...

Allopurinol (Lopurin ... an attack when you first start gout treatment until your body adjusts to the new drug. Your doctor will likely give you something to take if this happens, too.